The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Autologous tumor-infiltrating lymphocytes (HS-IT101) with low-dose lymphodepletion and IL-2 infusion for the treatment of advanced solid tumors: A phase I clinical trial.
 
Ning Li
No Relationships to Disclose
 
Di Wu
No Relationships to Disclose
 
Yuan Fang
No Relationships to Disclose
 
Yu Jiang
No Relationships to Disclose
 
Xinhua Zhang
Employment - Qingdao Sino-Cell Biomedicine Co., Ltd.
Leadership - Qingdao Sino-Cell Biomedicine Co., Ltd.
 
Wenna Liu
Employment - Qingdao Sino-Cell Biomedicine Co., Ltd.
Leadership - Qingdao Sino-Cell Biomedicine Co., Ltd.
 
Xiaonan Sun
Employment - Qingdao Sino-Cell Biomedicine Co., Ltd.
Leadership - Qingdao Sino-Cell Biomedicine Co., Ltd.
 
Pengxiang Wang
Employment - Qingdao Sino-Cell Biomedicine Co., Ltd.
Leadership - Qingdao Sino-Cell Biomedicine Co., Ltd.
 
Yi Zhao
Employment - Qingdao Sino-Cell Biomedicine Co., Ltd.
Leadership - Qingdao Sino-Cell Biomedicine Co., Ltd.